After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Acadia Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Acadia Pharmaceuticals Inc is $2.47B. A total of 0.89 million shares were traded on the day, compared to an average of 1.69M shares.
In the most recent transaction, Schneyer Mark C. sold 9,733 shares of ACAD for 15.28 per share on Aug 19 ’24. After the transaction, the EVP, CHIEF FINANCIAL OFFICER now owns 43,735 company shares. In a previous transaction on Aug 19 ’24, Teehan Brendan sold 9,534 shares at 15.28 per share. ACAD shares that EVP, COO, HEAD OF COMMERCIAL owns now total 52,177.
Among the insiders who sold shares, DAVIS STEPHEN disposed of 31,747 shares on Aug 19 ’24 at a per-share price of $15.28. This resulted in the CEO holding 186,555 shares of ACAD after the transaction. In another insider transaction, Schneyer Mark C. sold 975 shares at $14.79 per share on Jun 10 ’24. Company shares held by the EVP, CHIEF FINANCIAL OFFICER now total 34,564.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ACAD has a high of $32.59 and a low of $14.31.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ACAD’s latest balance sheet shows that the firm has $520.71M in Cash & Short Term Investments as of fiscal 2021. There were $64.43M in debt and $96.07M in liabilities at the time. Its Book Value Per Share was $3.12, while its Total Shareholder’s Equity was $540.89M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ACAD is Buy with a score of 4.14.
